• Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 04 Feb 2025 03:21:10   America/New_York


    Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat February 4, 2025 Share Link copied to clipboard. Denali Therapeutics Inc. ( NASDAQ:DNLI - Get Free Report ) has b
    Read more...
Share on,